Chimeric Antigen Receptor

Development of chimeric antigen receptor (CAR) T-cell immunotherapy for glioblastoma targeting epidermal growth factor receptor variant III (EGFRvIII)
Anthony K Park, Saul Priceman, Ethan Gerdts, Wen-Chung Chang, Sarah Wright, Stephen J Forman, Christine E Brown

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P119; DOI: 10.1186/2051-1426-3-S2-P119
Development and optimization of PSCA-specific CAR T cells for the treatment of bone metastatic prostate cancer
Ethan Gerdts, Saul Priceman, Dileshni Tilakawardane, Anthony Park, Wen-Chung Chang, Sarah Wright, Christine E Brown, Stephen J Forman

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P115; DOI: 10.1186/2051-1426-3-S2-P115
Charachterization and functional analysis of scFv-based CARs to redirect T cells to IL13Rα2-positive glioma
Giedre Krenciute, Simone Krebs, David Torres, Gianpietro Dotti, Maciej S Lesniak, Irina V Balyasnikova, Stephen Gottschalk

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P116; DOI: 10.1186/2051-1426-3-S2-P116
A bispecific chimeric antigen receptor molecule enhances T cell activation through dual immunological synapse formation and offsets antigen escape in glioblastoma
Meenakshi Hegde, Zakaria Grada, Antonella Pignata, Amanda Wakefield, Kristen Fousek, Kevin Bielamowicz, Kevin Chow, Vita Brawley, Tiara Byrd, Stephen Gottschalk, Malini Mukherjee, Winfried S Wels, Matthew Baker, Giapietro Dotti, Jordan Orange, Nabil Ahmed

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) O3; DOI: 10.1186/2051-1426-3-S2-O3
Improving adoptive T cell therapy with adenoviruse armed with TNF-α and IL-2
Riikka Havunen, Mikko Siurala, Suvi Parviainen, Simona Bramante, Dipongor Saha, Siri Tähtinen, Markus Vähä-Koskela, Michael Behr, Dirk Nettelbeck, Anja Ehrhardt, Akseli Hemminki

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P41; DOI: 10.1186/2051-1426-3-S2-P41
Clinical development of IL13Rα2-targeting CAR T cells for the treatment of glioblastoma
Christine E Brown, Renate Starr, Brenda Aguilar, Alfonso Brito, Brenda Chang, Aniee Sarkissian, Lihong Weng, Michael Jensen, Michael E Barish, Behnam Badie, Stephen J Forman

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P114; DOI: 10.1186/2051-1426-3-S2-P114
A Phase I study of an HLA-DPB1*0401-restricted T cell receptor targeting MAGE-A3 for patients with metastatic cancers
Yong-Chen Lu, Linda Parker, Tangying Lu, Zhili Zheng, Xin Yao, Paul F Robbins, Pierre van der Bruggen, Christopher A Klebanoff, Christian S Hinrichs, Stephanie Goff, Richard Sherry, Udai Kammula, James C Yang, Steven A Rosenberg

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P158; DOI: 10.1186/2051-1426-3-S2-P158
Development of HER2-specific chimeric antigen receptor T cells for the treatment of breast-to-brain metastasis
Saul Priceman, Brenda Aguilar, Renate Starr, Dileshni Tilakawardane, Anthony Park, Ethan Gerdts, Wen-Chung Chang, Sarah Wright, Stephen J Forman, Christine E Brown

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P121; DOI: 10.1186/2051-1426-3-S2-P121
Fas expression in memory CD8+ T cell subsets augments cellular differentiation and effector function
Tori Yamamoto, Anthony Leonardi, Hui Liu, Ena Wang, Luca Gattinoni, Anthony Cruz, Claudia Ouyang, Richard Siegel, Nicholas Restifo, Christopher A Klebanoff

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P329; DOI: 10.1186/2051-1426-3-S2-P329
Targeting FRβ+ tumor associated macrophages with car T cells in ovarian cancer
Rachel C Lynn, Takami Matsuyama, Daniel J Powell

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P32; DOI: 10.1186/2051-1426-3-S2-P32

Main menu

Chimeric Antigen Receptor

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Chimeric Antigen Receptor

Pages